M&A Deal Summary

Tsinghua Unisplendour Acquires Linxens SA

On June 28, 2018, Tsinghua Unisplendour acquired electrical equipment company Linxens SA from CVC Capital Partners for 2.5B USD

Acquisition Highlights
  • This is Tsinghua Unisplendour’s 1st transaction in the Electrical Equipment sector.
  • This is Tsinghua Unisplendour’s largest (disclosed) transaction.
  • This is Tsinghua Unisplendour’s 1st transaction in France.

M&A Deal Summary

Date 2018-06-28
Target Linxens SA
Sector Electrical Equipment
Buyer(s) Tsinghua Unisplendour
Sellers(s) CVC Capital Partners
Deal Type Add-on Acquisition
Deal Value 2.5B USD

Target

Linxens SA

Guyancourt, France
Linxens SA is a manufacturer of connectors for smart cards. Linxens was founded in 1986 and is based in Guyancourt, France.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Tsinghua Unisplendour

China

Category Company
Founded 1999
Sector Semiconductors
DESCRIPTION

Tsinghua Unisplendour Co. Ltd. is a chip manufacturer includes smart-card chips. Tsinghua Unisplendour was founded in 1999 and is based in China.


DEAL STATS #
Overall 3 of 3
Sector (Electrical Equipment) 1 of 1
Type (Add-on Acquisition) 2 of 2
Country (France) 1 of 1
Year (2018) 1 of 1
Size (of disclosed) 1 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2013-11-11 RDA Microelectronics

Shanghai, China

RDA Microelectronics, Inc. is a fabless radio frequency (RF) semiconductor design company in China. RDA designs RF semiconductors to address a broad range of applications including 2G cellular, wireless local loop, and 3G cellular. RDA Microelectronics was founded in 2004 and is based in Shanghai, China.

Buy $910M

Seller(S) 1

SELLER

CVC Capital Partners

Luxembourg, Luxembourg

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 1981
PE ASSETS 177.0B EUR
Size Mega
Type Sector Agnostic
DESCRIPTION

CVC Capital Partners is a global private equity firm focused on investments in large companies located in Europe, North America, and Asia. CVC looks for opportunities with stable cash flows and talented management, and will consider businesses in a variety of industries. Target sectors include textiles, industrial products, waste management, building materials, energy/utilities, business services, financial services, distribution, healthcare, media, semiconductors, and gaming. CVC can handle transactions valued from €200 million to €10 billion. CVC Capital Partners was formed in 1981 and is based in Luxembourg.


DEAL STATS #
Overall 141 of 173
Sector (Electrical Equipment) 2 of 2
Type (Add-on Acquisition) 51 of 63
Country (France) 7 of 10
Year (2018) 6 of 8
Size (of disclosed) 9 of 54
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2018-06-28 BJ s

Marlborough, Massachusetts, United States

BJ's is a warehouse club operator on the East Coast of the United States. BJ's delivers significant value to our members, consistently offering 25% or more savings on a representative basket of manufacturer-branded groceries compared to traditional supermarket competitors. BJ's provides a curated assortment focused on perishable products, continuously refreshed general merchandise, gas and other ancillary services to deliver a differentiated shopping experience that is further enhanced by our omnichannel capabilities. BJ's was incorporated in 1984 and is based in Westborough, Massachusetts.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2018-06-29 Recordati

Milan, Italy

Recordati is an international pharmaceutical group dedicated to the research, development, manufacturing and marketing of pharmaceuticals. Headquartered in Milan, Italy, Recordati has operations in the main European countries, in Russia, other Central and Eastern European countries, Turkey, North Africa, the United States of America, Canada, Mexico and in some South American countries. An efficient field force of medical representatives promotes a wide range of innovative pharmaceuticals, both proprietary and under license, in a number of therapeutic areas including a specialized business dedicated to treatments for rare diseases. Recordati was founded in 1926 and is based in Milan, Italy.

Buy -